Protective effect of berberine on doxorubicin‑induced acute hepatorenal toxicity in rats

Chen,Xueyan; Zhang,Yu; Zhu,Zhongning; Liu,Huanlong; Guo,Huicai; Xiong,Chen; Xie,Kerang; Zhang,Xiaofei; Su,Suwen

doi:10.3892/mmr.2016.5017

Protective effect of berberine on doxorubicin‑induced acute hepatorenal toxicity in rats

Authors:
- Xueyan Chen
- Yu Zhang
- Zhongning Zhu
- Huanlong Liu
- Huicai Guo
- Chen Xiong
- Kerang Xie
- Xiaofei Zhang
- Suwen Su
View Affiliations

Affiliations: The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China, The Family Planning Research Institute of Hebei, Shijiazhuang, Hebei 050000, P.R. China, Pharmaceutical Department, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China
Published online on: March 21, 2016 https://doi.org/10.3892/mmr.2016.5017
Pages: 3953-3960

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Doxorubicin (DOX), a potent broad‑spectrum chemotherapeutic agent used for the treatment of several types of cancer, is largely limited due to its serious side effects on non‑target organs. Thus, the present study aimed to investigate whether berberine (Ber), an isoquinoline alkaloid, could reduce DOX‑induced acute hepatorenal toxicity in rats. Fifty rats were randomly divided into five groups: i) Control group, ii) DOX group, iii) DOX+Ber (5 mg kg) group; iv) DOX+Ber (10 mg kg), and v) DOX+Ber (20 mg kg) group. In the tests, body weight, organ index, general condition and mortality were observed. In addition, the serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST), total cholesterol (TCHO) and blood urea nitrogen (BUN) were determined to evaluate hepatorenal function. Hepatorenal toxicity was further assessed using hematoxylin and eosin stained sections. Furthermore, the levels of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and malondialdehyde (MDA) in rat serum or tissue homogenate were also assessed to determine the mechanisms of action. Results suggested that pretreatment with Ber ameliorated the DOX‑induced liver and kidney injury by lowering the serum ALT, AST, TCHO and BUN levels, and the damage observed histologically, such as hemorrhage and focal necrosis of liver and kidney tissues induced by DOX were also attenuated by Ber. Furthermore, Ber also exerted certain antioxidative properties through reversing the changes in the levels of MDA, SOD, GSH and MDA induced by DOX. These findings indicate that Ber has protective effects against DOX‑induced acute hepatorenal toxicity in rats. Combination of Ber with DOX is a novel strategy that has the potential for protecting against DOX‑induced hepatorenal toxicity in clinical practice.

View Figures

View References

1	Cheng C, Xue W, Diao H, Xia S, Zuo L, He A, Gao F, Huang Z, Chen J and Zhang J: Antitumor activity and toxicological properties of doxorubicin conjugated to [alpha], [beta]-poly [(2-hydroxyethyl)-L-aspartamide] administered intraperitoneally in mice. Anticancer Drugs. 21:362–371. 2010. View Article : Google Scholar : PubMed/NCBI
2	Tangpong J, Miriyala S, Noel T, Sinthupibulyakit C, Jungsuwadee P and St Clair DK: Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana. Neuroscience. 175:292–299. 2011. View Article : Google Scholar :
3	Cardoso S, Santos RX, Carvalho C, Correia S, Pereira GC, Pereira SS, Oliveira PJ, Santos MS, Proença T and Moreira PI: Doxorubicin increases the susceptibility of brain mitochondria to Ca(2+)-induced permeability transition and oxidative damage. Free Radic Biol Med. 45:1395–1402. 2008. View Article : Google Scholar : PubMed/NCBI
4	Kalender Y, Yel M and Kalender S: Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology. 209:39–45. 2005. View Article : Google Scholar : PubMed/NCBI
5	Bárdi E, Bobok I, Voláh A, Kappelmayer J and Kiss C: Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. Pathol Oncol Res. 13:249–253. 2007. View Article : Google Scholar : PubMed/NCBI
6	Yang XL, Fan CH and Zhu HS: Photo-induced cytotoxicity of malonic acid [C(60)]fullerene derivatives and its mechanism. Toxicol In Vitro. 16:41–46. 2002. View Article : Google Scholar : PubMed/NCBI
7	Badkoobeh P, Parivar K, Kalantar SM, Hosseini SD and Salabat A: Effect of nano-zinc oxide on doxorubicin-induced oxidative stress and sperm disorders in adult male Wistar rats. Iran J Reprod Med. 11:355–364. 2013.
8	Li L, Takemura G, Li Y, Miyata S, Esaki M, Okada H, Kanamori H, Khai NC, Maruyama R, Ogino A, et al: Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation. 113:535–543. 2006. View Article : Google Scholar : PubMed/NCBI
9	Yeh YC, Lai HC, Ting CT, Lee WL, Wang LC, Wang KY, Lai HC and Liu TJ: Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol. 74:969–980. 2007. View Article : Google Scholar : PubMed/NCBI
10	Tang LQ, Wang FL, Zhu LN, Lv F, Liu S and Zhang ST: Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy. Mol Biol Rep. 40:3913–3923. 2013. View Article : Google Scholar
11	Wang Y, Huang Y, Lam KS, Li Y, Wong WT, Ye H, Lau CW, Vanhoutte PM and Xu A: Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res. 82:484–492. 2009. View Article : Google Scholar : PubMed/NCBI
12	Derosa G, Maffioli P and Cicero AF: Berberine on metabolic and cardiovascular risk factors: An analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther. 12:1113–1124. 2012. View Article : Google Scholar : PubMed/NCBI
13	Cho BJ, Im EK, Kwon JH, Lee KH, Shin HJ, Oh J, Kang SM, Chung JH and Jang Y: Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1 2 pathway in vascular smooth muscle cells. Mol Cells. 20:429–434. 2005.
14	Li J, Pan Y, Kan M, Xiao X, Wang Y, Guan F, Zhang X and Chen L: Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase. Life Sci. 98:24–30. 2014. View Article : Google Scholar : PubMed/NCBI
15	Hsu YY, Tseng YT and Lo YC: Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth. Toxicol Appl Pharmacol. 272:787–796. 2013. View Article : Google Scholar : PubMed/NCBI
16	Marin-Neto JA, Maciel BC, Secches AL and Gallo Junior L: Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin Cardiol. 11:253–260. 1988. View Article : Google Scholar : PubMed/NCBI
17	Zhao X, Zhang J, Tong N, Liao X, Wang E, Li Z, Luo Y and Zuo H: Berberine attenuates doxorubicin-induced cardiotoxicity in mice. J Int Med Res. 39:1720–1727. 2011. View Article : Google Scholar : PubMed/NCBI
18	Kelishomi RB, Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI and Dehpour AR: Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology. 243:96–104. 2008. View Article : Google Scholar
19	Jing L, Wu Y, Wu J, Zhao J, Zuo D and Peng S: Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity. Eur J Pharmacol. 659:224–232. 2011. View Article : Google Scholar : PubMed/NCBI
20	Hou XW, Jiang Y, Wang LF, Xu HY, Lin HM, He XY, He JJ and Zhang S: Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities. Toxicol Lett. 187:40–44. 2009. View Article : Google Scholar : PubMed/NCBI
21	You JS, Pan TL and Lee YS: Protective effects of Danshen (Salvia miltiorrhiza) on adriamycin-induced cardiac and hepatic toxicity in rats. Phytother Res. 21:1146–1152. 2007. View Article : Google Scholar : PubMed/NCBI
22	Outomuro D, Grana DR, Azzato F and Milei J: Adriamycin-induced myocardial toxicity: New solutions for an ole problems? Int J Cardiol. 117:6–15. 2007. View Article : Google Scholar
23	Piscitelli SC, Rodvold KA, Rushing DA and Tewksbury DA: Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small-cell lung cancer. Clin Pharmacol Ther. 53:555–561. 1993. View Article : Google Scholar : PubMed/NCBI
24	Swain SM, Whaley FS and Ewer MS: Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer. 97:2869–2879. 2003. View Article : Google Scholar : PubMed/NCBI
25	King SL, Mohiuddin JJ and Dekaney CM: Paneth cells expand from newly created and preexisting cells during repair after doxorubicin-induced damage. Am J Physiol Gastrointest Liver Physiol. 305:G151–G162. 2013. View Article : Google Scholar : PubMed/NCBI
26	Tong N, Zhang J, Chen Y, Li Z, Luo Y, Zuo H and Zhao X: Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncol Lett. 3:1263–1267. 2012.PubMed/NCBI
27	Abd El-Wahab AE, Ghareeb DA, Sarhan EE, Abu-Serie MM and El Demellawy MA: In vitro biological assessment of Berberis vulgaris and its active constituent, berberine: Antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complement Altern Med. 13:2182013. View Article : Google Scholar : PubMed/NCBI
28	Yan K, Zhang C, Feng J, Hou L, Yan L, Zhou Z, Liu Z, Liu C, Fan Y, Zheng B and Xu Z: Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur J Pharmacol. 661:1–7. 2011. View Article : Google Scholar : PubMed/NCBI
29	Youn MJ, So HS, Cho HJ, Kim HJ, Kim Y, Lee JH, Sohn JS, Kim YK, Chung SY and Park R: Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria caspase-mediated pathway in HeLa cells. Biol Pharm Bull. 31:789–795. 2008. View Article : Google Scholar : PubMed/NCBI
30	Hsu YY, Chen CS, Wu SN, Jong YJ and Lo YC: Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase Akt-dependent mechanism in NSC34 motor neuron-like cells. Eur J Pharm Sci. 46:415–425. 2012. View Article : Google Scholar : PubMed/NCBI
31	Lv XX, Yu XH, Wang HD, Yan YX, Wang YP, Lu DX, Qi RB, Hu CF and Li HM: Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-α-caspase signaling pathway. Chin J Integr Med. 19:424–431. 2013. View Article : Google Scholar
32	Cheng F, Wang Y, Li J, Su C, Wu F, Xia WH, Yang Z, Yu BB, Qiu YX and Tao J: Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol. 167:936–942. 2013. View Article : Google Scholar
33	Shen L and Ji HF: The mechanisms of ROS-photogeneration by berberine, a natural isoquinoline alkaloid. J Photochem Photobiol B. 99:154–156. 2010. View Article : Google Scholar : PubMed/NCBI
34	Zhao X, Zhang J, Tong N, Chen Y and Luo Y: Protective effects of berberine on doxorubicin-induced hepatotoxicity in mice. Biol Pharm Bull. 35:796–800. 2012. View Article : Google Scholar : PubMed/NCBI